GE Healthcare Vivo 30 - Manual (Page 2)

Technical Specifications
Settings/Performance
Ventilation Modes • PSV (Pressure Support Ventilation)
• PCV (Pressure Control Ventilation)
• CPAP (Continuous Positive Airway Pressure)
Device Modes • Clinical
• Home
IPAP/EPAP 4 to 30 cmH
2
O / 2 to 20 cmH
2
O or IPAP -2 cmH
2
O
CPAP 4 to 20 cmH
2
O
Breath Rate 4 to 40 BPM
Inspiratory Time 0.3 to 5 s
Rise Time 1 to 9
Inspiratory Trigger (eSync) 1 to 9, Off
Expiratory Trigger 1 to 9
Ramp Function 10 – 60 min
Humidification 1 to 9, (10 to 30 mgH
2
O/L)
Audible alarm 1 to 9
Maximum flow > 200 litres/min
Minimal Inspiratory Time Off, 0.3 – 3.0 s
Maximal Inspiratory Time 0.3 – 3.0 s, Off
Noise level (at 10 cmH
2
O constant pressure) Less than 30 dB(A)
Indications
Pressure; bar graph and digital data 0 to 30 cmH
2
O
Calculated tidal volume accuracy ± 20%
Leakage calculation accuracy ± 20%
Total Breath Rate BPM (Breaths Per Minute)
I/E Ratio 1 :10 to 10 :1
Power Supplies
Mains supply 100 to 240 V AC
External battery 12/24 V DC
Operating Conditions
Recommended mask leakage 20 to 40 litres/min at 10 cmH
2
O
Minimum mask leakage 12 litres/min at 4 cmH
2
O
Alarms
Audible Alarm Level 45 to 85 dB(A)
Low/High pressure alarm, Low volume alarm, Low/High leakage alarm,
Low external DC Warning, Low power alarm, Internal function failure
alarms.
Dimensions
W x H x D 185 x 230 x 227 mm
Weight 3.1 kg
Air outlet 22 mm male conical standard connector
Breas Medical AB · Företagsvägen 1 · SE-435 33 Mölnlycke · Sweden
Phone +46 31 86 88 00 · Fax +46 31 86 88 10 · [email protected] · www.breas.com · www.gehealthcare.com
* Vivo by Breas and eSync are trademarks by General Electric Company.
© 2012 General Electric Company – All rights reserved.
General Electric Company reserves the right to make changes in specifications and features
shown herein, or discontinue the product described at any time without notice or obligation.
Contact your GE representative for the most current information.
GE, the GE Monogram and imagination at work are trademarks of General Electric Company.
Br
eas Medical AB/EN/October 2012/DOC1222952, r
ev1